Phase 1 clinical study to assess the safety of a novel drug delivery system providing long‐term topical steroid therapy for chronic rhinosinusitis-Reference-Cited by-同舟云学术

Phase 1 clinical study to assess the safety of a novel drug delivery system providing long‐term topical steroid therapy for chronic rhinosinusitis

Author:

Douglas Richard G.¹,Psaltis Alkis J.²,Rimmer Joanne³⁴,Kuruvilla Tom⁵,Cervin Anders⁶,Kuang Yina⁷

Affiliation:

1. Department of SurgeryThe University of Auckland Auckland New Zealand

2. Department of Otolaryngology Head and Neck SurgeryThe Queen Elizabeth Hospital Woodville South South Australia

3. Monash Health Melbourne Australia

4. Department of SurgeryMonash University Melbourne Australia

5. Otolaryngology–Head and Neck SurgerySpecialists at Forte 2 Christchurch New Zealand

6. University of Queensland Centre for Clinical ResearchRoyal Brisbane & Women's Hospital Campus Herston QLD Australia

7. Lyra Therapeutics, Inc Watertown MA

Funder

Lyra Therapeutics, Inc.

Publisher

Wiley

Subject

Otorhinolaryngology,Immunology and Allergy

Link

Reference30 articles.

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

3. Unified Airway Disease;Otolaryngologic Clinics of North America;2023-02